Evidence map›Paper›PMID 34156290›Full record

ArticlemSystems2021

Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance, and Persistence.

Kirsi Savijoki, Henna Myllymäki, Hanna Luukinen, Lauri Paulamäki, Leena-Maija Vanha-Aho, Aleksandra Svorjova, Ilkka Miettinen, Adyary Fallarero, Teemu O Ihalainen, Jari Yli-Kauhaluoma and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSystems, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Drug resistance mechanisms inFrontiers in pharmacology · 2026
    Review
  4. Article
  5. Journal of bacteriology · 2025
    Review
  6. Exploiting thioether reactivity to label mycobacterial glycans.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Protease shaving ofMicrobiology spectrum · 2025
    Article
  8. Article
  9. Editorial: Factors associated with drug resistance and virulence ofFrontiers in cellular and infection microbiology · 2024
    Article
  10. Article
  11. Microorganisms · 2023
    Article
  12. mSystems · 2023
    Article
  13. Frontiers in cellular and infection microbiology · 2022
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Kirsi Savijoki *Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinkigrid.7737.4, Helsinki, Finland.
Henna Myllymäki *Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Hanna LuukinenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Lauri PaulamäkiFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Leena-Maija Vanha-AhoFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Aleksandra SvorjovaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Ilkka MiettinenDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinkigrid.7737.4, Helsinki, Finland.
Adyary FallareroDrug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinkigrid.7737.4, Helsinki, Finland.
Teemu O IhalainenFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Jari Yli-KauhaluomaDrug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland.
Tuula A NymanInstitute of Clinical Medicine, Department of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Mataleena ParikkaFaculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Tampere University · FIUniversity of Helsinki · FIOslo University Hospital · NO

Funding

Academy of Finland (Suomen Akatemia) 322010Academy of Finland (Suomen Akatemia) 326674Foundation of the Finnish Anti-Tuberculosis Association Foundation of the Finnish Anti-Tuberculosis AssociationJane and Aatos Erkko Foundation Jane and Aatos Erkko FoundationResearch Council of Norway INFRASTRUKTUR-program 295910Sigrid Juselius Foundation Sigrid Juselius Foundation
6 · The paper itself

Abstract

The complex cell wall and biofilm matrix (ECM) act as key barriers to antibiotics in mycobacteria. Here, the ECM and envelope proteins of Mycobacterium marinum ATCC 927, a nontuberculous mycobacterial model, were monitored over 3 months by label-free proteomics and compared with cell surface proteins on planktonic cells to uncover pathways leading to virulence, tolerance, and persistence. We show that ATCC 927 forms pellicle-type and submerged-type biofilms (PBFs and SBFs, respectively) after 2 weeks and 2 days of growth, respectively, and that the increased CelA1 synthesis in this strain prevents biofilm formation and leads to reduced rifampicin tolerance. The proteomic data suggest that specific changes in mycolic acid synthesis (cord factor), Esx1 secretion, and cell wall adhesins explain the appearance of PBFs as ribbon-like cords and SBFs as lichen-like structures. A subpopulation of cells resisting 64× MIC rifampicin (persisters) was detected in both biofilm subtypes and already in 1-week-old SBFs. The key forces boosting their development could include subtype-dependent changes in asymmetric cell division, cell wall biogenesis, tricarboxylic acid/glyoxylate cycle activities, and energy/redox/iron metabolisms. The effect of various ambient oxygen tensions on each cell type and nonclassical protein secretion are likely factors explaining the majority of the subtype-specific changes. The proteomic findings also imply that Esx1-type protein secretion is more efficient in planktonic (PL) and PBF cells, while SBF may prefer both the Esx5 and nonclassical pathways to control virulence and prolonged viability/persistence. In conclusion, this study reports the first proteomic insight into aging mycobacterial biofilm ECMs and indicates biofilm subtype-dependent mechanisms conferring increased adaptive potential and virulence of nontuberculous mycobacteria.

Indexed as

biofilm matrixbiofilmscell surface proteomicsMycobacterium marinumpersistencetolerance

Identifiers

PMID34156290
PMCPMC8269238
OpenAlexW3165304523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.